Quotes 5-day view End-of-day quote Hong Kong Stock Exchange
06/17/2021
06/18/2021
06/21/2021
06/22/2021
06/23/2021
Date
23.55
22.55
22.9
22.75
23.45
Last
7097022
18645870
9561630
7241831
7294316
Volume
+1.51% -4.25% +1.55% -0.66% +3.08% Change
Estimated financial data (e) CNY USD
Sales 2021
527 B 81 415 M 81 415 M
Net income 2021
8 067 M 1 246 M 1 246 M
Net Debt 2021
16 870 M 2 606 M 2 606 M
P/E ratio 2021
7,56x
Yield 2021
3,86%
Sales 2022
587 B 90 703 M 90 703 M
Net income 2022
8 848 M 1 367 M 1 367 M
Net Debt 2022
14 891 M 2 300 M 2 300 M
P/E ratio 2022
6,94x
Yield 2022
4,36%
Capitalization
61 017 M 9 424 M 9 425 M
EV / Sales 2021
0,15x
EV / Sales 2022
0,13x
Nbr of Employees
108 316
Free-Float
43,0%
Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical products to hospitals, other distributors, retail drug stores and clinics. The Retail Pharmacy segment is engaged in...
Ratings of Sinopharm Group Co., Ltd.
All news about SINOPHARM GROUP CO., LTD.
06/18 ASTRAZENECA : Argentine lab makes first half million doses of Russian COVID-19 ..RE
06/15 SINOPHARM GROUP CO., LTD. : Ex-dividend day for final dividendFA
06/09 China to study using CanSinoBIO COVID shots as a booster RE
06/08 Boyu, Sinopharm among bidders shortlisted for Mundipharma China - sources RE
06/04 Who senior adviser says having "very positive" conversations with sinovac an.. RE
06/02 MARKET CHATTER : Sinopharm Can Supply Over 1 Billion COVID-19 Vaccines in H2, Ch..MT
06/02 Bahrain, Facing a Covid Surge, Starts Giving Pfizer Boosters to Recipients of.. DJ
06/02 Bahrain Residents Who Are Over 50, Obese, Have Chronic Illnesses Urged To Get.. RE
06/02 Bahrain residents who are over 50, obese, have chronic illnesses urged to get.. RE
06/01 SINOPHARM : WHO Grants Emergency-Use Approval to Sinovac's COVID-19 VaccineMT
06/01 WHO Urges More Funding From Rich Nations for Covid Vaccines, Endorses Sinovac.. DJ
06/01 Foreign Governments Request Covid-19 Vaccine Doses as U.S. Prepares to Share .. DJ
06/01 Foreign Governments Request Covid-19 Vaccine Doses as U.S. Prepares to Share DJ
06/01 WHO approves Sinovac COVID shot in second Chinese milestone RE
05/31 Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion.. RE
News in other languages on SINOPHARM GROUP CO., LTD.
Boyu, Sinopharm among bidders shortlisted for Mundipharma China - sources
Chart SINOPHARM GROUP CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
18
Last Close Price
19,55 CNY
Average target price
23,87 CNY
Spread / Average Target
22,1%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
